1. 重症胰腺炎胰腺局部ACE2- Ang(1-7)-Mas受体轴改变及其作用机制研究，国家自然科学基金委

2. ACE/ACE2作为吉西他滨对胰腺癌临床疗效的分子标志物研究，首都卫生发展科研专项基金

3. 黄芪在胰腺癌治疗中通过调节细胞自噬逆转血管生成抑制剂耐药的作用机制研究，北京市中医药科技发展资金项目

4. 晚期胃癌阿帕替尼靶向治疗的分子标志物筛选与临床疗效预测研究，北京市医院管理局“青苗”计划专项经费

5. 大承气汤通过上调ACE2-Ang（1-7）-Mas受体轴影响热毒血瘀胰腺癌瘤内细菌微环境提高吉西他滨敏感性研究。首都医科大学科研培育基金

6.黄芪通过调节肠道菌群提高晚期胃癌免疫检查点抑制剂药物敏感性的随机对照临床研究,北京市属医院科研培育计划

 1.  Mingyang Ma, Kun Shang, Jiewei Wang1, XiaojingTeng, Peng Li, Jing Wang（通讯作者）. A patient with multiple primarymalignant neoplasms with high variant allele frequencies of RB1, TP53, and TERT.Biomarker Research. 2024,12(20)（IF 11.1）(https://doi.org/10.1186/s40364-024-00567-z)

2.  Jingting Wang, Yan Ma, Haishan Lin, Jing Wang(共同通讯作者)，Bangwei Cao1.Predictive biomarkers forimmune-related adverse events in cancer patients treated with immune-checkpointinhibitors. BMC Immunology.2024,25:8. （IF:3.59）

https://doi.org/10.1186/s12865-024-00599-y

3.  Wang J, Ma X, Ma Z, Ma Y, Wang J(共同通讯作者), Cao B (2022) Research Progress of Biomarkers for ImmuneCheckpoint Inhibitors on Digestive System Cancers. Frontiers in Immunology. doi:10.3389/fimmu.2022.810539（IF:7.561）

4.  Yan Ma, Kun Shang, Shanshan Wu, Jing Wang(共同通讯作者)，Bangwei Cao: The Prognostic Value ofAlbumin-Globulin Ratio and Eosinophil-Neutrophil Ratio in Patients withAdvanced Tumors Undergoing Treatment with PD-1/PD-L1 Inhibitors,Nutrition and Cancer. 2022.2032764 (IF:2.9) DOI:10.1080/01635581.

5.  Jing Wang, Xiao Ma, Kun Shang, Shanshan Wu,Yan Ma, Zhongjun Ma, Bangwei Cao. Safety and Efficacy of Spleen AminopeptideOral Lyophilized Powder for Improving Quality of Life and Immune Response inPatients with Advanced Breast Cancer: A Multicenter, Randomized, Double-blind,Placebo-controlled Clinical Trial. Anti-Cancer Drugs2021. 32(10):1067-1075（IF: 2.26)( DOI：10.1097/CAD.0000000000001109)

6.  Jingting Wang, Xiao Ma, Hai Si, Zhongjun Ma,Yan Ma, Jing Wang（通讯作者）, Bangwei Cao. Role of long non‑coding RNA H19 in therapy resistance of digestive systemcancers. Molecular Medicine. 2021, 27:1（IF: 6.354)

7.  Jing Wang, Lei Zhao, Kun Shang, Fang Liu,Juanjuan Che, Huihui Li, Bangwei Cao Long Non-coding RNAH19, a novel therapeutic target for pancreatic cancer Molecular Medicine.2020,26:30 （IF: 4.096)